1,955
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Radiofrequency ablation of small follicular neoplasms: initial clinical outcomes

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 931-937 | Received 09 Mar 2017, Accepted 12 May 2017, Published online: 25 May 2017

References

  • Leenhardt L, Hejblum G, Franc B, et al. (1999). Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 84:24–8.
  • Gilliland FD, Hunt WC, Morris DM, Key CR. (1997). Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the surveillance, epidemiology and end results (seer) program 1973–1991. Cancer 79:564–73.
  • Duggal R, Rajwanshi A, Gupta N, Vasishta RK. (2011). Interobserver variability amongst cytopathologists and histopathologists in the diagnosis of neoplastic follicular patterned lesions of thyroid. Diagn Cytopathol 39:235–41.
  • Goldstein RE, Netterville JL, Burkey B, Johnson JE. (2002). Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg 235:656–62. discussion 62-4.
  • Dosen D, Turic M, Smalcelj J, et al. (2003). The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma. Head Neck 25:521–8.
  • Yoon JH, Kim EK, Hong SW, et al. (2008). Sonographic features of the follicular variant of papillary thyroid carcinoma. J Ultrasound Med 27:1431–7.
  • Shih SR, Shun CT, Su DH, et al. (2005). Follicular variant of papillary thyroid carcinoma: Diagnostic limitations of fine needle aspiration cytology. Acta Cytol 49:383–6.
  • Na DG, Baek JH, Jung SL, et al. (2017). Core needle biopsy of the thyroid: 2016 consensus statement and recommendations from Korean Society of Thyroid Radiology. Korean J Radiol 18:217–37.
  • Yoon RG, Baek JH, Lee JH, et al. (2014). Diagnosis of thyroid follicular neoplasm: Fine-needle aspiration versus core-needle biopsy. Thyroid 24:1612–7.
  • Gulcelik NE, Gulcelik MA, Kuru B. (2008). Risk of malignancy in patients with follicular neoplasm: Predictive value of clinical and ultrasonographic features. Arch Otolaryngol Head Neck Surg 134:1312–5.
  • Mauri G, Cova L, Monaco CG, et al. (2017). Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA). Int J Hyperthermia 33:295–9.
  • Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. (2000). Tumor ablation with radio-frequency energy. Radiology 217:633–46.
  • Dupuy DE, Monchik JM, Decrea C, Pisharodi L. (2001). Radiofrequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery 130:971–7.
  • Kim JH, Baek JH, Sung JY, et al. (2017). Radiofrequency ablation of low-risk small papillary thyroidcarcinoma: preliminary results for patients ineligible for surgery. Int J Hyperthermia 33:212–9.
  • Sun J, Liu X, Zhang Q, et al. (2016). Papillary thyroid carcinoma treated with radiofrequency ablation in a patient with hypertrophic cardiomyopathy: a case report. Korean J Radiol 17:558–61.
  • Dobrinja C, Bernardi S, Fabris B, et al. (2015). Surgical and pathological changes after radiofrequency ablation of thyroid nodules. Int J Endocrinol 2015:576576.
  • Jeong WK, Baek JH, Rhim H, et al. (2008). Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–50.
  • Sacks D, McClenny TE, Cardella JF, Lewis CA. (2003). Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–S202.
  • Haugen BR, Alexander EK, Bible KC, et al. (2016). 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133.
  • Na DG, Lee JH, Jung SL, et al. (2012). Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol 13:117–25.
  • McHenry CR, Phitayakorn R. (2011). Follicular adenoma and carcinoma of the thyroid gland. Oncologist 16:585–93.
  • Gharib H. (2004). Changing trends in thyroid practice: understanding nodular thyroid disease. Endocr Pract 10:31–9.
  • Linos D, Economopoulos KP, Kiriakopoulos A, et al. (2013). Scar perceptions after thyroid and parathyroid surgery: comparison of minimal and conventional approaches. Surgery 153:400–7.
  • Yoo C, Choi HJ, Im S, et al. (2013). Fine needle aspiration cytology of thyroid follicular neoplasm: cytohistologic correlation and accuracy. Korean J Pathol 47:61–6.
  • Dabelic N, Matesa N, Matesa-Anic D, Kusic Z. (2010). Malignancy risk assessment in adenomatoid nodules and suspicious follicular lesions of the thyroid obtained by fine needle aspiration cytology. Coll Antropol 34:349–54.
  • Deveci MS, Deveci G, LiVolsi VA, Baloch ZW. (2006). Fine-needle aspiration of follicular lesions of the thyroid. Diagnosis and follow-up. CytoJournal 3:9.
  • Nasrollah N, Trimboli P, Guidobaldi L, et al. (2013). Thin core biopsy should help to discriminate thyroid nodules cytologically classified as indeterminate. A new sampling technique. Endocrine 43:659–65.
  • Sung JY, Na DG, Kim KS, et al. (2012). Diagnostic accuracy of fine-needle aspiration versus core-needle biopsy for the diagnosis of thyroid malignancy in a clinical cohort. Eur Radiol 22:1564–72.
  • Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. (2002). Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 26:41–4.
  • Sclabas GM, Staerkel GA, Shapiro SE, et al. (2003). Fine-needle aspiration of the thyroid and correlation with histopathology in a contemporary series of 240 patients. Am J Surg 186:702–9; discussion 9-10.
  • Giorgadze T, Rossi ED, Fadda G, et al. (2004). Does the fine-needle aspiration diagnosis of "Hurthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Diagn Cytopathol 31:307–12.
  • Choi YJ, Yun JS, Kim DH. (2009). Clinical and ultrasound features of cytology diagnosed follicular neoplasm. Endocr J 56:383–9.
  • Schlumberger M, Leboulleux S. (2015). Treatment of distant metastases from follicular cell-derived thyroid cancer. F1000Prime Rep 7:22.
  • Ito Y, Hirokawa M, Higashiyama T, et al. (2007). Prognosis and prognostic factors of follicular carcinoma in Japan: importance of postoperative pathological examination. World J Surg 31:1417–24.
  • Baek JH, Kim YS, Sung JY, et al. (2011). Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation. Am J Roentgenol 197:W331–6.
  • Monchik JM, Donatini G, Iannuccilli J, Dupuy DE. (2006). Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg 244:296–304.
  • Park KW, Shin JH, Han BK, et al. (2011). Inoperable symptomatic recurrent thyroid cancers: preliminary result of radiofrequency ablation. Ann Surg Oncol 18:2564–8.
  • Kim JH, Yoo WS, Park YJ, et al. (2015). Efficacy and safety of radiofrequency ablation for treatment of locally recurrent thyroid cancers smaller than 2 cm. Radiology 276:909–18.
  • Garberoglio R, Aliberti C, Appetecchia M, et al. (2015). Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J Ultrasound 18:423–30.
  • Deandrea M, Limone P, Basso E, et al. (2008). US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 34:784–91.
  • Spiezia S, Garberoglio R, Milone F, et al. (2009). Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 19:219–25.
  • Shin JH, Baek JH, Chung J, et al. (2016). Ultrasonography diagnosis and imaging-based management of thyroid nodules: revised Korean Society of Thyroid Radiology consensus statement and recommendations. Korean J Radiol 17:370–95.
  • Moses W, Weng J, Sansano I, et al. (2010). Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy. World J Surg 34:2589–94.
  • Nikiforov YE, Steward DL, Robinson-Smith TM, et al. (2009). Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092–8.
  • Huh JY, Baek JH, Choi H, et al. (2012). Symptomatic benign thyroid nodules: efficacy of additional radiofrequency ablation treatment session – prospective randomized study. Radiology 263:909–16.
  • Paramo JC, Mesko T. (2008). Age, tumor size, and in-office ultrasonography are predictive parameters of malignancy in follicular neoplasms of the thyroid. Endocr Pract 14:447–51.
  • Lo CY, Chan WF, Lam KY, Wan KY. (2005). Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival. Ann Surg 242:708–15.
  • Ito Y, Oda H, Miyauchi A. (2016). Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas. Endocr J 63:323–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.